EcoDrugPlus

Solute Carrier Family 6 Member 2

Ensembl ID : ENSDLAG00005002040
Gene Symbol: SLC6A2
1 Cross references
204 Possible Orthologues:

Solute Carrier Family 6 Member 3

Ensembl ID : ENSDLAG00005013489
Gene Symbol: SLC6A3
1 Cross references
167 Possible Orthologues:

Solute Carrier Family 6 Member 4a

Ensembl ID : ENSDLAG00005006056
Gene Symbol: SLC6A4A
1 Cross references
203 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSDLAG00005015088
Gene Symbol: SLC6A9
1 Cross references
207 Possible Orthologues:

Solute Carrier Family 9 Member A3, Tandem Duplicate 2

Ensembl ID : ENSDLAG00005006534
Gene Symbol: SLC9A3.2
1 Cross references
235 Possible Orthologues:

Spleen Tyrosine Kinase

Ensembl ID : ENSDLAG00005022273
Gene Symbol: SYK
1 Cross references
203 Possible Orthologues:

Steroid-5-Alpha-Reductase, Alpha Polypeptide 2b

Ensembl ID : ENSDLAG00005025572
Gene Symbol: SRD5A2B
1 Cross references
192 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSDLAG00005025506
Gene Symbol: SOAT1
1 Cross references
211 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSDLAG00005008827
Gene Symbol: TACR2
1 Cross references
200 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSDLAG00005001481
Gene Symbol: TACR3
1 Cross references
172 Possible Orthologues:

Tachykinin Receptor 3-Like

Ensembl ID : ENSDLAG00005007160
Gene Symbol: TACR3L
1 Cross references
201 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSDLAG00005014253
Gene Symbol: TERT
1 Cross references
188 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).